Overview
Jacinda Sampson is a Neurologist in Stanford, California. Dr. Sampson is rated as an Elite provider by MediFind in the treatment of Myotonic Dystrophy Type 2. Her top areas of expertise are Oculodentodigital Dysplasia, Myotonic Dystrophy Type 2, Myotonic Dystrophy, Paramyotonia Congenita, and Thymectomy.
Her clinical research consists of co-authoring 49 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles and participated in 1 clinical trial in the study of Myotonic Dystrophy Type 2.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Pasteur Dr, Stanford, CA 94305
725 Welch Rd, Palo Alto, CA 94304
Additional Areas of Focus
Dr. Sampson has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Stanford Health Care
John Day is a Neurologist in Stanford, California. Dr. Day is rated as a Distinguished provider by MediFind in the treatment of Myotonic Dystrophy Type 2. His top areas of expertise are Dysferlinopathy, Facioscapulohumeral Muscular Dystrophy (FSHD), Duchenne Muscular Dystrophy, and Paramyotonia Congenita.
Stanford Health Care
Maxwell Greene is a Neurologist in Stanford, California. Dr. Greene is rated as a Distinguished provider by MediFind in the treatment of Myotonic Dystrophy Type 2. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3.
Stanford Health Care
Neelam Goyal is a Neurologist and a Neuroradiologist in Stanford, California. Dr. Goyal is rated as a Distinguished provider by MediFind in the treatment of Myotonic Dystrophy Type 2. Her top areas of expertise are Myasthenia Gravis, Inclusion Body Myositis, Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Myotonic DystrophyDr. Sampson isElite. Learn about Myotonic Dystrophy.
- Myotonic Dystrophy Type 2Dr. Sampson isElite. Learn about Myotonic Dystrophy Type 2.
- Oculodentodigital DysplasiaDr. Sampson isElite. Learn about Oculodentodigital Dysplasia.
- Oculodentodigital Dysplasia Dominant
- Paramyotonia CongenitaDr. Sampson isElite. Learn about Paramyotonia Congenita.
- Distinguished
- Alexander DiseaseDr. Sampson isDistinguished. Learn about Alexander Disease.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- CACH SyndromeDr. Sampson isDistinguished. Learn about CACH Syndrome.
- Canavan DiseaseDr. Sampson isDistinguished. Learn about Canavan Disease.
- Farber LipogranulomatosisDr. Sampson isDistinguished. Learn about Farber Lipogranulomatosis.
- Hereditary Spastic ParaparesisDr. Sampson isDistinguished. Learn about Hereditary Spastic Paraparesis.
- Advanced
- Adrenoleukodystrophy (ALD)Dr. Sampson isAdvanced. Learn about Adrenoleukodystrophy (ALD).
- Andermann SyndromeDr. Sampson isAdvanced. Learn about Andermann Syndrome.
- Becker Muscular DystrophyDr. Sampson isAdvanced. Learn about Becker Muscular Dystrophy.
- Charcot-Marie-Tooth DiseaseDr. Sampson isAdvanced. Learn about Charcot-Marie-Tooth Disease.
- Coenzyme Q Cytochrome C Reductase Deficiency
- Delta-SarcoglycanopathyDr. Sampson isAdvanced. Learn about Delta-Sarcoglycanopathy.
- Experienced
- ADULT SyndromeDr. Sampson isExperienced. Learn about ADULT Syndrome.
- Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
- Arthrogryposis Multiplex CongenitaDr. Sampson isExperienced. Learn about Arthrogryposis Multiplex Congenita.
- Benign Autosomal Dominant MyopathyDr. Sampson isExperienced. Learn about Benign Autosomal Dominant Myopathy.
- Beta-Propeller Protein-Associated Neurodegeneration
- Boucher-Neuhauser SyndromeDr. Sampson isExperienced. Learn about Boucher-Neuhauser Syndrome.